Preoperative and postoperative staging in endometrial cancer – a prospective study

Česká verzia

Authors: O. Brych ¹; J. Drozenová ² ; T. Pichlík ³ ; Martin Hruda ³ ; Lukáš Rob ³ ; H. Robová ³ ; P. Waldauf ⁴ ; P. Themistocleous ³; Michael Jiří Halaška ³
Authors place of work: Porodnicko-gynekologická klinika Nemocnice Pardubického kraje, a. s. ¹; Ústav patologie, 3. LF UK a FNKV, Praha ²; Gynekologicko-porodnická klinika 3. LF UK a FNKV, Praha ³; Klinika anesteziologie a resuscitace 3. LF UK a FNKV, Praha ⁴
Published in the journal: Ceska Gynekol 2024; 89(1): 5-10
Category: Original Article
doi: https://doi.org/10.48095/cccg20245

Summary

Objective: The aim of this study was to determine how often changes the stage of the tumour in definitive histology against preoperative clinical stage in patient cohort with diagnosed endometrial cancer.

Methods: We evaluated prospectively a cohort of 166 patients with endometrial cancer. They all underwent abdominal hysterectomy, bilateral salpingo-oophorectomy, sentinel lymph node biopsy. Patients with high-risk tumours also pelvic lymfadenectomy. We collected data of preoperative diagnostic biopsy and postoperative definitive histology. The data were statistically processed.

Results: Detection of sentinel lymph node was successful in 71.1%, bilateral successful detection was in 40.6%. Discrepancy of tumour grade between preoperative biopsy and definitive histology was generally 31.4%. Upgrading of the tumour was in 22 (14.4%) cases, downgrading in 26 (17%) cases. Upgrade from low-risk to high-risk group of tumours was noticed in eight cases. Histopathological tumour type changed in 6.6%, 4.6% moved to histopathologic high-risk group. The tumour stage changed in definite histology in 57.3%, in 19.2% of cases moved from stage low/intermediate-risk group to intermediate-high/high-risk disease group.

Conclusion: Correct assessment of preoperative clinical stage and histological grade of endometrial cancer is burdened with a high inaccuracy rate. A lot of cases is up-staged after surgical staging and moved to intermediate-high/high-risk disease group. Results confirm the importance of oncogynaecologic centre II. evaluation of histopathology findings from diagnostic biopsies made in referring hospitals. Sentinel lymph node biopsy should be performed even in clinically low/intermediate-risk disease group.

Keywords:

endometrial cancer – tumour stage – tumour grade – sentinel lymph node detection

Zdroje

1. Dusek L, Muzik J, Kubásek M et al. Epidemiology of malignant tumours in Czech Republic. Masaryk University. 2005 [online]. Available from: http: //www.svod.cz.

2. Liberis A, Mareti E, Pratilas G et al. Dilatation and curettage in endometrial cancer. What is the correlation with hysterectomy histology? A 14 years retrospective cohort study. J BUON 2021; 26 (5): 1775–1781.

3. Corr BR, Carrubba A, Sheeder J et al. Histopathology discrepancy of preoperative endometrial sampling and final specimen: how does this influence selective lymph node dissection? Int J Gynecol Cancer 2017; 27 (2): 297–301. doi: 10.1097/IGC.0000000000000866.

4. Lago V, Martín B, Ballesteros E et al. Tumor grade correlation between preoperative biopsy and final surgical specimen in endometrial cancer: the use of different diagnostic methods and analysis of associated factors. Int J Gynecol Cancer 2018; 28 (7): 1258–1263. doi: 10.1097/IGC.0000000000001304.

5. Torrent A, Amengual J, Sampol CM et al. Sentinel lymph node biopsy in endometrial cancer: dual injection, dual tracer – a multidisciplinary exhaustive approach to nodal staging. Cancers (Basel) 2022; 14 (4): 929. doi: 10.3390/ cancers14040929.

6. Ruiz R, Gorostidi M, Jaunarena I et al. Maximizing sentinel node detection in endometrial cancer with dual cervical and transcervical fundal indocyanine green injection: 5-year single--center prospective study. Eur J Obstet Gynecol Reprod Biol 2021; 261: 59–64. doi: 10.1016/ j.ejogrb.2021.04.015.

7. Ruiz R, Gorostidi M, Jaunarena I et al. Sentinel node biopsy in endometrial cancer with dual cervical and fundal indocyanine green injection. Int J Gynecol Cancer 2018; 28 (1): 139–144. doi: 10.1097/IGC.0000000000001151.

8. Marchocki Z, Cusimano MC, Clarfield L et al. Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics. Am J Obstet Gynecol 2021; 225 (4): 367.e1–367.e39. doi: 10.1016/j.ajog.2021.05.034.

9. Persson J, Salehi S, Bollino M et al. Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial) -the final step towards a paradigm shift in surgical staging. Eur J Cancer 2019; 116: 77–85. doi: 10.1016/ j.ejca.2019.04.025.

10. Salman L, Cusimano MC, Marchocki Z et al. Sentinel lymph node mapping in high-grade endometrial cancer. Curr Oncol 2022; 29 (2): 1123–1135. doi: 10.3390/curroncol29020 096.

11. Novák O, Bartoš P, Bučko R. Indocyanine green as a new trend in sentinel lymphatic node detection in oncogynecology. Ceska Gynekol 2022; 87 (1): 54–61. doi: 10.48095/cccg202 254.

12. Visser NC, Reijnen C, Massuger LF et al. Accuracy of endometrial sampling in endometrial carcinoma: a systematic review and meta-analysis. Obstet Gynecol 2017; 130 (4): 803–813. doi: 10.1097/AOG.0000000000002261.

13. Buranawattanachoke S, Leelahakorn S, Tangjitgamol S et al. Comparison between clinical and surgical staging for endometrial cancer in Thailand. Asian Pac J Cancer Prev 2009; 10 (4): 685–690.

14. Palmér M, Åkesson Å, Marcickiewicz J et al. Accuracy of transvaginal ultrasound versus MRI in the PreOperative Diagnostics of low-grade Endometrial Cancer (PODEC) study: a prospective multicentre study. Clin Radiol 2023; 78 (1): 70–79. doi: 10.1016/j.crad.2022.09. 118.

15. Ľubušký M, Dzvincuk P, Pilka R et al. Před-operační zhodnocení myometriální invaze u pacientek s karcinomem endometria pomocí ultrazvuku a magnetické rezonance. Ceska Gynekol 2006; 71 (5): 394–398.

16. Alcázar JL, Gastón B, Navarro B et al. Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with endometrial cancer: a systematic review and meta-analysis. J Gynecol Oncol 2017; 28 (6): e86. doi: 10.3802/jgo.2017.28.e86.

17. Crosbie EJ, Kitson SJ, McAlpine JN et al. Endometrial cancer. Lancet 2022; 399 (10333): 1412–1428. doi: 10.1016/S0140-6736 (22) 00323-3.